🇺🇸 FDA
Patent

US 11040097

Method of conferring a protective immune response to norovirus

granted A61KA61K2039/5258A61K2039/543

Quick answer

US patent 11040097 (Method of conferring a protective immune response to norovirus) held by Takeda Vaccines, Inc. expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/5258, A61K2039/543, A61K2039/55572, A61K2039/55583